Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.

B Osara Health discloses its role as the primary cancer support provider in Swiss Re’s independent Rehabilitation Watch 2025 report, which confirmed a 25:1 return…
posteditor
posteditor
Articles: 16137

Other News